Abstract
An increasing number of cancer patients worldwide, especially in third world countries, have raised concern to explore natural drug resources, such as the less explored fresh water filamentous cyanobacteria. Six strains of cyanobacteria (Phormidium sp. CCC727, Geitlerinema sp. CCC728, Arthrospira sp. CCC729, Phormidium sp. CCC731, Phormidium sp. CCC730, and Leptolyngbya sp. CCC732) were isolated (paddy fields and ponds in the Banaras Hindu University, campus) and five strains screened for anticancer potential using human colon adenocarcinoma (HT29) and human kidney adenocarcinoma (A498) cancer cell lines. Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 were the most potent as determined by examination of morphological features and by inhibition of growth by graded concentrations of crude extracts and thin-layer chromatography (TLC) eluates. Cell cycle analysis and multiplex assays using cancer biomarkers also confirmed Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 as cancer drug resources. Apoptotic studies in the cells of A498 (cancer) and MCF-10A (normal human epithelial) exposed to crude extracts and TLC fractions revealed no significant impact on MCF-10A cells emphasizing its importance in the development of antican...Continue Reading
References
Jan 1, 1997·Journal of Natural Products·G M CraggK M Snader
Aug 1, 1997·Applied and Environmental Microbiology·U NübelG Muyzer
Oct 24, 1998·Journal of Natural Products·G G HarriganF A Valeriote
Jun 8, 2001·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·C JacksonP Sambrook
Nov 17, 2001·Current Opinion in Pharmacology·A B da RochaG Schwartsmann
Mar 25, 2005·Organic Letters·Eric H AndrianasoloWilliam H Gerwick
May 12, 2005·Journal of Agricultural and Food Chemistry·Li-chen WuIn-Wei Lu
Aug 26, 2006·The Journal of Organic Chemistry·Alberto Plaza, Carole A Bewley
Sep 29, 2006·Cellular and Molecular Life Sciences : CMLS·A CatassiP Russo
Mar 6, 2007·Phytochemistry·Lik Tong Tan
Feb 2, 2008·Astrobiology·David SchwartzmanAlex Pavlov
May 1, 2008·Journal of the American Chemical Society·Rebecca A MedinaKerry L McPhail
Jul 24, 2008·Marine Drugs·R F MartinsV M Vasconcelos
Dec 2, 2009·Environmental Toxicology·Catherine BernardLarelle Fabbro
Sep 3, 2010·Journal of Natural Products·Lilibeth A SalvadorHendrik Luesch
Sep 10, 2010·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Alejandro M S MayerNobuhiro Fusetani
Sep 23, 2010·BMC Complementary and Alternative Medicine·Wan-Loy ChuPhaik-Eem Lim
Oct 30, 2010·Current Opinion in Biotechnology·Joshawna K NunneryWilliam H Gerwick
Dec 1, 2010·Marine Drugs·Linn OftedalLars Herfindal
Jan 31, 2012·Chemistry & Biology·William H Gerwick, Bradley S Moore
Nov 22, 2012·Marine Drugs·Margarida CostaRosário Martins
May 29, 2013·Drug Discovery Today·Lik Tong Tan
Apr 12, 2014·Scientific Reports·Hyun Uk LeeJouhahn Lee
Citations
Dec 23, 2016·Journal of Applied Microbiology·A SrivastavaR K Asthana
Jan 19, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nozomi TairaShinkichi Tawata
Dec 13, 2017·Frontiers in Pharmacology· NiveshikaArun K Mishra
Jan 13, 2018·Frontiers in Microbiology·Magda A FurmaniakKrzysztof F Waleron
Oct 28, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhiqiang YeGuanli Huang
Dec 15, 2016·Frontiers in Microbiology· NiveshikaVinay K Singh
Jan 31, 2021·Life·Steffen BrauneJan-Heiner Küpper
Jul 6, 2021·3 Biotech·Shaloo VermaAnil Kumar Saxena